The Urokinase Receptor Is Expressed in Invasive Breast Cancer but not in Normal Breast Tissue

Cancer Research

Volumn 54, Issue 4, 1994, Pages 861-866

  Bianchi, E ^a   Cohen, R L ^b   Thor, A T ^c   Todd, R F ^d   Mizukami, I F ^d   Lawrence, D A ^b   Ljung, B M ^b   Shuman, M A ^b   Smith, H S ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; POLYCLONAL ANTIBODY; UROKINASE;

ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; BREAST PAPILLOMA; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROMA;

BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0028347646     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Liotta, L. A., Thorgeirsson, U. P., and Garbisa, S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev., 1: 277-288, 1982.
2. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44: 139-266, 1985.
3. Vassalli, J. D., Baccino, D., and Belin, D. A cellular binding site for the Mr 55, 000 form of the human plasminogen activator urokinase. J. Cell Biol., 100: 86-92, 1985.
4. Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F. and Assoian, R. K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA, 82: 4939-4943, 1985.
5. Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., and Blasi, F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J., 9: 467-474, 1990.
6. Ellis, V., Scully, M. F., and Kakkar, V. V. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator: potentiation by U937 cells. J. Biol. Chem., 264: 2185-2188, 1989.
7. Estreicher, A., Mühlhauser, J., Carpentier, J. L., Orci, L., and Vassalli, J. D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol., 111: 783-792, 1990.
8. Mignatti, P., Robbins, E., and Rifkin, D. B. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47: 487-498, 1986.
9. Ossowski, L. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell, 52: 321-328, 1988.
10. Hearing, V. J., Law, L. W., Corti, A., Appella, E., and Blasi, F. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res., 48: 1270-1278, 1988.
11. Schmitt, M., Janicke, F., and Graeff, H. Tumor-associated fibrinolysis: the prognostic relevance of plasminogen activators uPa and tPa in human breast cancer. Blood Coagul. Fibrinolysis, 1: 695-702, 1990.
12. Sumiyoshi, K., Serizawa, K., Urano, T., Takada, Y., Takada, A., and Baba, S. Plasminogen activator system in human breast cancer. Int. J. Cancer, 50: 345-348, 1992.
13. Janicke, F., Schmitt, M., Hafter, R., Hollrieder, A., Babic, R., Ulm, K., Gossner, W., and Graeff, H. Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer. Fibrinolysis, 4: 69-78, 1990.
14. Duffy, M. J., Reilly, D., O'Sullivan, C., O'Higgins, N., Fennelly, J. J., and Andreasen, P. Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res., 50: 6827-6829, 1990.
15. Foekens, J. A., Schmitt, M., van Putten, W. L. J., Peters, H. A., Bontenbal, M., Janicke, R., and Klijn, J. G. M. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res., 52: 6101-0105, 1992.
16. Todd, R. R., III, Adams, M. D., Rogers, C. E., Tripp, L. R., and Liu, D. Y. Evidence for an intracellular pool of a migration inhibitory factor-associated, activation antigen of human mononuclear phagocytes, Mo3e. J. Immunol., 140: 1095-1100, 1988.
17. Stampfer, M. R., Vlodavsky, I., Smith, H. S., Ford, R., Becker, F. R., and Riggs, J. Fibronectin production by human mammary epithelial cells in culture. J. Natl. Cancer Inst., 67: 253-261, 1981.
18. Mizukami, I. F., Vinjamuri, S. D., Trochelman, R. D., and Todd, R. F., III. A structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol., 144: 1841-1848, 1990.
19. Min, H. Y., Semnani, R., Mizukami, I. F., Watt, K., Todd, R. F., III, and Liu, D. Y. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol., 148: : 3636-3642, 1992.
20. Cohen, R. L., Xi, X. P., Crowley, C. W., Lucas, B. K., Levinson, A. D., and Shuman, M. A. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood, 78: 479-487, 1991.
21. Graham, F L., and van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-462, 1973.
22. Miles, L. A., Levin, E. G., Plescia, J., Collen, D., and Plow, E. F. Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. Blood, 72: 628-635, 1988.
23. Barnathan, E. S., Kuo, A., Rosenfeld, L., Kariko, K., Leski, M., Robbiati, F., Nolli, M. L., Henkin, J., and Cines, D. B. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. J. Biol. Chem., 265: 2865-2872, 1990.
24. Barnathan, E. S., Kuo, A., Kariko, K., Rosenfeld, L., Murray, S. C., Behrendt, N., R0nne, E., Weiner, D., Henkin, J., and Cines, D. B. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood, 76: 1795-1806, 1990.
25. Mignatti, P., Mazzieri, R., and Rifkin, D. B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol., 113: 1193-1201, 1991.
26. Bacharach, E., Itin, A., and Keshet, E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in upregulating physiological angiogen-esis. Proc. Natl. Acad. Sci. USA, 89: 10686-10690, 1992.
27. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
28. Pyke, C., Graem, N., Ralfkiaer, E., Rønne, E., Høyer-Hansen, G., Brunner, N., and Danø, K. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53: 1911-1915, 1993.
29. Mizukami, I. F., Vinjamuri, S. D., Perini, F., Liu, D. Y., and Todd, R. F., III. Purification, biochemical composition, and biosynthesis of the Mo3 activation antigen expressed on the plasma membrane of human mononuclear phagocytes. J. Immunol., 147: 1331-1337, 1991.